IMDS’s NHanceIT Microcatheter for Complex PCI Launched in the United States 

September 11, 2026—Interventional Medical Device Solutions (IMDS) announced the United States launch of NHanceIT. The device is an over-the-wire, single-lumen microcatheter built on the company’s Skeleton Backbone technology that is engineered to improve lesion crossing in challenging coronary anatomy.

IMDS, based in Roden, the Netherlands, develops specialty catheters for complex percutaneous coronary interventions (PCI), complex higher-risk and indicated patient (CHIP), and chronic total occlusion (CTO) procedures.

According to IMDS, its Skeleton Backbone technology seeks to address the growing complexity of coronary interventions by replacing traditional construction with a solid, laser-cut stainless-steel tube tailored across critical catheter sections to address distinct procedural challenges.

Jaikirshan Khatri, MD, Director of Cardiac Catheterization Laboratories at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, performed one of the first United States commercial cases using NHanceIT.

“This catheter is truly incredible,” commented Dr. Khatri in the company’s press release. “In tortuous and calcified anatomy, you need strong push and torque to get to the lesion and then you must cross. NHanceIT’s ability to deliver through challenging anatomy is impressive.”

Emmanouil Brilakis, MD, who is Director of the Center for Complex Coronary Interventions at Allina Health Minneapolis Heart Institute in Minneapolis, Minnesota, is codeveloper of NHanceIT.

“I had the opportunity to provide clinical input during the development of NHanceIT, with the goal of addressing the practical demands operators face in complex PCI,” stated Dr. Brilakis in the press release. “What stood out most about NHanceIT was how familiar it felt to use. Yet when the case became more demanding, it provided the additional support needed, making it practical to incorporate into everyday complex PCI.”

IMDS advised that it will continue expanding availability of NHanceIT and partnering with CTO and CHIP operators to build real-world experience with the Skeleton Backbone platform. Skeleton Backbone is now available in the United States in the NHanceIT device and IMDS’s Micro Rx and ShapeIT rapid exchange microcatheters.